In the Norwegian cohort, ICC and kappa was 0.92 and 0.92 and 0.73 and 0.75 for stromal PDGFRα and PDGFRβ, respectively. This evidence concerns the gene PDGFRA and intrahepatic cholangiocarcinoma.